Molecular Changes in Circulating MicroRNAs' Expression and Oxidative Stress in Adults with Mild Cognitive Impairment: A Biochemical and Molecular Study

Overview

Journal Clin Interv Aging

Publisher Dove Medical Press

Specialty Geriatrics

Date 2021 Jan 15

PMID 33447019

Citations 11

Authors

Hadeel A Al-Rawaf

Ahmad H Alghadir

Sami A Gabr

Affiliations

Soon will be listed here.

Abstract

Background: The release of miRNAs in tissue fluids significantly recommends its use as non-invasive diagnostic biomarkers for the progression and pathogenesis of mild cognitive impairment (MCI) in aged patients.

Objective: The potential role of circulated miRNAs in the pathogenesis of MCI and its association with cellular oxidative stress, apoptosis, and circulated BDNF, Sirtuin 1 (SIRT1), and dipeptidyl peptidase-4 (DPP4) were evaluated in older adults with MCI.

Methods: A total of 150 subjects aged 65.4±3.7 years were recruited in this study. The participants were classified into two groups: healthy normal (n=80) and MCI (n=70). Real-time PCR analysis was performed to estimate the relative expression of miRNAs; miR-124a, miR-483-5p, miR-142-3p, and miR-125b, and apoptotic-related genes , , and in the sera of MCI and control subjects. In addition, oxidative stress parameters; MDA, NO, SOD, and CAT; as well as plasma DPP4 activity, BDNF, SIRT1 levels were colorimetrically estimated.

Results: The levels of miR-124a and miR-483-5p significantly increased and miR-142-3p and miR-125b significantly reduced in the serum of MCI patients compared to controls. The expressed miRNAs significantly correlated with severe cognitive decline, measured by MMSE, MoCA, ADL, and memory scores. The expression of Bax, and caspase-3 apoptotic inducing genes significantly increased and Bcl-2 antiapoptotic gene significantly reduced in MCI subjects compared to controls. In addition, the plasma levels of MDA, NO, and DPP4 activity significantly increased, and the levels of SOD, CAT, BDNF, and SIRT1 significantly reduced in MCI subjects compared to controls. The expressed miRNAs correlated positively with NO, MDA, DPP4 activity, BDNF, and SIRT-1, and negatively with the levels of CAT, SOD, , , and genes.

Conclusion: Circulating miR-124a, miR-483-5p, miR-142-3p, and miR-125b significantly associated with severe cognitive decline, cellular oxidative stress, and apoptosis in patients with MCI. Thus, it could be potential non-invasive biomarkers for the diagnosis of MCI with high diagnostic performance.

Citing Articles

Role of exercise on ncRNAs and exosomal ncRNAs in preventing neurodegenerative diseases: a narrative review.

Liu S, Zhang R, Hallajzadeh J Mol Med. 2025; 31(1):51.

PMID: 39920595 PMC: 11803956. DOI: 10.1186/s10020-025-01091-y.

Exploring the Role of Reactive Oxygen Species in the Pathogenesis and Pathophysiology of Alzheimer's and Parkinson's Disease and the Efficacy of Antioxidant Treatment.

Gogna T, Housden B, Houldsworth A Antioxidants (Basel). 2024; 13(9).

PMID: 39334797 PMC: 11429442. DOI: 10.3390/antiox13091138.

Rosuvastatin attenuates total-tau serum levels and increases expression of miR-124-3p in dyslipidemic Alzheimer's patients: a historic cohort study.

Usefi F, Rustamzadeh A, Ghobadi Z, Sadigh N, Mohebi N, Ariaei A Metab Brain Dis. 2024; 39(6):1201-1211.

PMID: 38896205 DOI: 10.1007/s11011-024-01371-2.

A randomized controlled trial on the effects of traditional Thai mind-body exercise (Ruesi Dadton) on biomarkers in mild cognitive impairment.

Khanthong P, Sriyakul K, Dechakhamphu A, Krajarng A, Kamalashiran C, Jayathavaj V Eur J Phys Rehabil Med. 2024; 60(4):604-610.

PMID: 38814196 PMC: 11403630. DOI: 10.23736/S1973-9087.24.08015-8.

Effects of DPP4 Inhibitors as Neuroprotective Drug on Cognitive Impairment in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis and Systematic Review.

Yuan Y, Zhang Y, Lei M, Guo X, Yang X, Ouyang C Int J Endocrinol. 2024; 2024:9294113.

PMID: 38379936 PMC: 10878760. DOI: 10.1155/2024/9294113.

References

Rodriguez-Martinez E, Martinez F, Espinosa-Garcia M, Maldonado P, Rivas-Arancibia S . Mitochondrial dysfunction in the hippocampus of rats caused by chronic oxidative stress. Neuroscience. 2013; 252:384-95. DOI: 10.1016/j.neuroscience.2013.08.018. View

Ishibashi Y, Matsui T, Maeda S, Higashimoto Y, Yamagishi S . Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate/insulin-like growth factor II receptor. Cardiovasc Diabetol. 2013; 12:125. PMC: 3765742. DOI: 10.1186/1475-2840-12-125. View

Krek A, Grun D, Poy M, Wolf R, Rosenberg L, Epstein E . Combinatorial microRNA target predictions. Nat Genet. 2005; 37(5):495-500. DOI: 10.1038/ng1536. View

Keller J, Schmitt F, Scheff S, Ding Q, Chen Q, Butterfield D . Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology. 2005; 64(7):1152-6. DOI: 10.1212/01.WNL.0000156156.13641.BA. View

Jiang M, Xiang Y, Wang D, Gao J, Liu D, Liu Y . Dysregulated expression of miR-146a contributes to age-related dysfunction of macrophages. Aging Cell. 2011; 11(1):29-40. DOI: 10.1111/j.1474-9726.2011.00757.x. View

Jin Y, Chen Z, Liu X, Zhou X . Evaluating the microRNA targeting sites by luciferase reporter gene assay. Methods Mol Biol. 2012; 936:117-27. PMC: 3646406. DOI: 10.1007/978-1-62703-083-0_10. View

Godfrey M, Majid D . Renal handling of circulating nitrates in anesthetized dogs. Am J Physiol. 1998; 275(1):F68-73. DOI: 10.1152/ajprenal.1998.275.1.F68. View

Goth L . A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta. 1991; 196(2-3):143-51. DOI: 10.1016/0009-8981(91)90067-m. View

Keller A, Backes C, Haas J, Leidinger P, Maetzler W, Deuschle C . Validating Alzheimer's disease micro RNAs using next-generation sequencing. Alzheimers Dement. 2016; 12(5):565-76. DOI: 10.1016/j.jalz.2015.12.012. View

10.

Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

11.

Saba R, Schratt G . MicroRNAs in neuronal development, function and dysfunction. Brain Res. 2010; 1338:3-13. DOI: 10.1016/j.brainres.2010.03.107. View

12.

Porteri C, Frisoni G . Biomarker-based diagnosis of mild cognitive impairment due to Alzheimer's disease: how and what to tell. A kickstart to an ethical discussion. Front Aging Neurosci. 2014; 6:41. PMC: 3959740. DOI: 10.3389/fnagi.2014.00041. View

13.

Jia L, Liu Y . Downregulated serum miR-223 servers as biomarker in Alzheimer's disease. Cell Biochem Funct. 2016; 34(4):233-7. DOI: 10.1002/cbf.3184. View

14.

Ansari A, Maffioletti E, Milanesi E, Marizzoni M, Frisoni G, Blin O . miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer's disease. Neurobiol Aging. 2019; 82:102-109. DOI: 10.1016/j.neurobiolaging.2019.06.005. View

15.

Zhang C, Li C, Chen S, Li Z, Ma L, Jia X . Hormetic effect of panaxatriol saponins confers neuroprotection in PC12 cells and zebrafish through PI3K/AKT/mTOR and AMPK/SIRT1/FOXO3 pathways. Sci Rep. 2017; 7:41082. PMC: 5253660. DOI: 10.1038/srep41082. View

16.

Jiang T, Yu J, Tan L . Novel disease-modifying therapies for Alzheimer's disease. J Alzheimers Dis. 2012; 31(3):475-92. DOI: 10.3233/JAD-2012-120640. View

17.

Nicolas F . Experimental validation of microRNA targets using a luciferase reporter system. Methods Mol Biol. 2011; 732:139-52. DOI: 10.1007/978-1-61779-083-6_11. View

18.

Ma X, Liu L, Meng J . MicroRNA-125b promotes neurons cell apoptosis and Tau phosphorylation in Alzheimer's disease. Neurosci Lett. 2017; 661:57-62. DOI: 10.1016/j.neulet.2017.09.043. View

19.

Zheng T, Chen T, Liu Y, Gao Y, Tian H . Increased plasma DPP4 activity predicts new-onset hypertension in Chinese over a 4-year period: possible associations with inflammation and oxidative stress. J Hum Hypertens. 2014; 29(7):424-9. DOI: 10.1038/jhh.2014.111. View

20.

Jeong H, Cohen D, Cui L, Supinski A, Savas J, Mazzulli J . Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway. Nat Med. 2011; 18(1):159-65. PMC: 3509213. DOI: 10.1038/nm.2559. View